Cargando…
Our Journey Through Advanced Therapies to Reduce Post-Infarct Scarring
Autores principales: | Roura, Santiago, Monguió-Tortajada, Marta, Prat-Vidal, Cristina, Gálvez-Montón, Carolina, Bayes-Genis, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553692/ https://www.ncbi.nlm.nih.gov/pubmed/34021471 http://dx.doi.org/10.1007/s12015-021-10190-2 |
Ejemplares similares
-
Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
por: Monguió-Tortajada, Marta, et al.
Publicado: (2017) -
Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites
por: Courageux, Yvan, et al.
Publicado: (2021) -
Preclinical Evaluation of the Immunomodulatory Properties of Cardiac Adipose Tissue Progenitor Cells Using Umbilical Cord Blood Mesenchymal Stem Cells: A Direct Comparative Study
por: Perea-Gil, Isaac, et al.
Publicado: (2015) -
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model
por: Monguió-Tortajada, Marta, et al.
Publicado: (2022) -
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)